Enzalutamide and olaparib synergistically suppress castration-resistant prostate cancer progression by promoting apoptosis through inhibiting nonhomologous end joining pathway

  • Impact factors: 3.054
  • Publication: ASIAN JOURNAL OF ANDROLOGY
  • Author:Dong Hui-Yu, Zang Pan, Bao Mei-Ling, Zhou Tian-Ren, Ni Chen-Bo, Ding Lei, Zhao Xu-Song, Li Jie, Liang Chao
  • DOI citation-doi:10.4103/aja202316
  • Date:2023-05-26

Related Products

$400.00$500.00

$400.00$500.00

$400.00$500.00

$400.00$500.00

$400.00$500.00

$400.00$500.00

Hot products

Hot citation